89bio Net Debt from 2010 to 2024
| ETNB Stock | USD 8.76 0.38 4.53% |
Net Debt | First Reported 2018-12-31 | Previous Quarter -184.9 M | Current Value -89.4 M | Quarterly Volatility 96.4 M |
Check 89bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 89bio's main balance sheet or income statement drivers, such as Tax Provision of 10 K, Depreciation And Amortization of 82.9 K or Interest Expense of 4.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.74. 89bio financial statements analysis is a perfect complement when working with 89bio Valuation or Volatility modules.
89bio | Net Debt |
Latest 89bio's Net Debt Growth Pattern
Below is the plot of the Net Debt of 89bio Inc over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. 89bio's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 89bio's overall financial position and show how it may be relating to other accounts over time.
| Net Debt | 10 Years Trend |
|
Net Debt |
| Timeline |
89bio Net Debt Regression Statistics
| Arithmetic Mean | (75,288,690) | |
| Coefficient Of Variation | (134.78) | |
| Mean Deviation | 82,209,453 | |
| Median | (11,234,000) | |
| Standard Deviation | 101,474,184 | |
| Sample Variance | 10297T | |
| Range | 277.8M | |
| R-Value | (0.76) | |
| Mean Square Error | 4612.7T | |
| R-Squared | 0.58 | |
| Significance | 0.0009 | |
| Slope | (17,340,437) | |
| Total Sum of Squares | 144158.1T |
89bio Net Debt History
Other Fundumenentals of 89bio Inc
89bio Net Debt component correlations
Click cells to compare fundamentals
About 89bio Financial Statements
89bio stakeholders use historical fundamental indicators, such as 89bio's Net Debt, to determine how well the company is positioned to perform in the future. Although 89bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in 89bio's assets and liabilities are reflected in the revenues and expenses on 89bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in 89bio Inc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Debt | -289.1 M | -274.6 M | |
| Net Debt To EBITDA | 2.15 | 1.18 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether 89bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of 89bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of 89bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on 89bio Inc Stock:Check out the analysis of 89bio Correlation against competitors. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 89bio. If investors know 89bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 89bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.96) | Return On Assets (0.41) | Return On Equity (0.73) |
The market value of 89bio Inc is measured differently than its book value, which is the value of 89bio that is recorded on the company's balance sheet. Investors also form their own opinion of 89bio's value that differs from its market value or its book value, called intrinsic value, which is 89bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 89bio's market value can be influenced by many factors that don't directly affect 89bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 89bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 89bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 89bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.